Jens Waschke

Jens Waschke

Auto-generated profile, based on publicly available information

Jens Waschke

Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, LMU Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2017 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
MRM. Y. Radeva
M. Y. Radeva
JWJ. Waschke
J. Waschke

1 January 2018 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
VSVolker Spindler
Volker Spindler
RERüdiger Eming
Rüdiger Eming
ESEnno Schmidt
Enno Schmidt
MAMasayuki Amagai
Masayuki Amagai
SGSergei Grando
Sergei Grando
JWJens Waschke
Jens Waschke

18 May 2020 in Acta Physiologica
Verified
Journal Article
Open access
PDF file
NSNicolas Schlegel
Nicolas Schlegel
KBKevin Boerner
Kevin Boerner
JWJens Waschke
Jens Waschke
Inflammatory bowel diseases (IBD) such as Crohn’s disease (CD) and Ulcerative colitis (UC) have a complex and multifactorial pathogenesis which is incompletely understood. A typical feature closely associated with clinical symptoms is impaired intestinal epithelial barrier function. Mounting evidence suggests that desmosomes, which together with tight junctions (TJ) and adherens junctions (AJ) form the intestinal epithelial barrier, play a distinct role in IBD pathogenesis. This is based on the finding that desmoglein (Dsg) 2, a cadherin‐type adhesion molecule of desmosomes, is required for maintenance of intestinal barrier properties both in vitro and in vivo, presumably via Dsg2‐mediated regulation of TJ. Mice deficient for intestinal Dsg2 show increased basal permeability and are highly susceptible to experimental colitis. In several cohorts of IBD patients, intestinal protein levels of Dsg2 are reduced and desmosome ultrastructure is altered suggesting that Dsg2 is involved in IBD pathogenesis. In addition to its adhesive function, Dsg2 contributes to enterocyte cohesion and intestinal barrier function. Dsg2 is also involved in enterocyte proliferation, barrier differentiation and induction of apoptosis, in part by regulation of p38MAPK and EGFR signalling. In IBD, the function of Dsg2 appears to be compromised via p38MAPK activation, which is a critical pathway for regulation of desmosomes and is associated with keratin phosphorylation in IBD patients. In this review, the current findings on the role of Dsg2 as a novel promising target to prevent loss of intestinal barrier function in IBD patients are discussed.

1 January 2018 in Annals of Anatomy - Anatomischer Anzeiger
Verified
Journal Article
Closed access
DKDaniela Kugelmann
Daniela Kugelmann
LSLeonard Stratmann
Leonard Stratmann
NNNils Nühlen
Nils Nühlen
FBFelix Bork
Felix Bork
SHSaskia Hoffmann
Saskia Hoffmann
JWJens Waschke
Jens Waschke

17 June 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MMMichael Meir
Michael Meir
NBNatalie Burkard
Natalie Burkard
HUHanna Ungewiß
Hanna Ungewiß
MDMarkus Diefenbacher
Markus Diefenbacher
Sven FlemmingSven Flemming
Sven Flemming
NSNicolas Schlegel
Nicolas Schlegel
Impaired intestinal epithelial barrier (IEB) function with loss of desmosomal junctional protein desmoglein 2 (DSG2) is a hallmark in the pathogenesis of inflammatory bowel disease (IBD). While previous studies have reported that glial cell line–derived neurotrophic factor (GDNF) promotes IEB function, the mechanisms are poorly understood. We hypothesized that GDNF is involved in the loss of DSG2, resulting in impaired IEB function as seen in IBD. In the inflamed intestine of patients with IBD, there was a decrease in GDNF concentrations accompanied by a loss of DSG2, changes of the intermediate filament system, and increased phosphorylation of p38 MAPK and cytokeratins. DSG2-deficient and RET-deficient Caco2 cells revealed that GDNF specifically recruits DSG2 to the cell borders, resulting in increased DSG2-mediated intercellular adhesion via the RET receptor. Challenge of Caco2 cells and enteroids with proinflammatory cytokines as well as dextran sulfate sodium–induced (DSS-induced) colitis in C57Bl/6 mice led to impaired IEB function with reduced DSG2 mediated by p38 MAPK–dependent phosphorylation of cytokeratins. GDNF blocked all inflammation-induced changes in the IEB. GDNF attenuates inflammation-induced impairment of IEB function caused by the loss of DSG2 through p38 MAPK–dependent phosphorylation of cytokeratin. The reduced GDNF in patients with IBD indicates a disease-relevant contribution to the development of IEB dysfunction.

1 February 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
VSVolker Spindler
Volker Spindler
JWJens Waschke
Jens Waschke
Pemphigus is a severe autoimmune-blistering disease of the skin and mucous membranes caused by autoantibodies reducing desmosomal adhesion between epithelial cells. Autoantibodies against the desmosomal cadherins desmogleins (Dsgs) 1 and 3 as well as desmocollin 3 were shown to be pathogenic, whereas the role of other antibodies is unclear. Dsg3 interactions can be directly reduced by specific autoantibodies. Autoantibodies also alter the activity of signaling pathways, some of which regulate cell cohesion under baseline conditions and alter the turnover of desmosomal components. These pathways include Ca2+, p38MAPK, PKC, Src, EGFR/Erk, and several others. In this review, we delineate the mechanisms relevant for pemphigus pathogenesis based on the histology and the ultrastructure of patients’ lesions. We then dissect the mechanisms which can explain the ultrastructural hallmarks detectable in pemphigus patient skin. Finally, we reevaluate the concept that the spectrum of mechanisms, which induce desmosome dysfunction upon binding of pemphigus autoantibodies, finally defines the clinical phenotype.